Poster Presentation Annual Meetings of the Endocrine Society of Australia and Society for Reproductive Biology and Australia and New Zealand Bone and Mineral Society 2016

Hypercalcaemia of immobility: a state of increased bone turnover (#349)

Veronica Wong 1 , Kirtan Ganda 1
  1. Concord Hospital, Concord, NSW, Australia

Immobility-induced hypercalcaemia is a diagnosis of exclusion for non-PTH mediated hypercalcaemia. The proposed pathophysiology underlying this is uncoupling of bone turnover, with greater deceleration in bone formation and increased resorption.

A 49-year-old Caucasian male with background of splenectomy presented with abdominal pain, purpuric rash and renal impairment secondary to streptococcus septicaemia. He developed purpura fulminans with ischaemic auto-amputation of his limbs. During ICU admission, he was intubated, required nasogastric feeding for two weeks and had a prolonged delirium. His serum calcium rose from normal to 3.12mmol/L at 7 weeks with suppressed PTH of 0.3pmol/L. His confusion and renal function had improved after a short period of intermittent haemodiafiltration. There was no history of malignancy and he was on no predisposing medications.

On examination, he appeared euvolaemic and haemodynamically stable. He was neurologically intact. He had bilateral below knee and hand amputations. Although he was moved passively, he remained bedbound. He had no lymphadenopathy or focal bony tenderness.

Results included PTH 0.6pmol/L(1.3-7.6), 25-hydroxyvitamin-D 35nmol/L(>50nmol/L), 1,25-hydroxyvitamin-D 19(60-200), electrophoresis showed a polyclonal inflammatory response, serum ACE level 41U/L(30-55), spot calcium:creat was 0.8mmol/mol cr(0-0.4), PTHrP <0.2pmol/L, TSH 4.5mIU/L(0.27-4.2), fT4 16pmol/L(12-25), morning cortisol 230nmol/L, ACTH 12.9pmol/L(<10), urine DPD/Cr 41.1(2.3-5.4). Chest imaging did not reveal hilar lymphadenopathy. Bone scan showed no osteoblastic deposits.

A provisional diagnosis of immobility-related hypercalcaemia was made. He was given 30mg pamidronate resulting in normalisation of calcium for 81 days. He developed recurrent hypercalcaemia to 2.9mmol/L and bone turnover markers were markedly elevated: P1NP 1100ug/L, CTX 3094ng/L(100-600). 4mg zoledronic acid was then given which resulted in normalisation of serum calcium.

Non-PTH mediated hypercalcaemia due to immobility presents with hypercalciuria and trabecular bone loss due to reduced osteoblast activity. Inflammation and acidity can predispose to increased bone resorption. Fluid and bisphosphonates are common treatments with remobilisation. Denosumab and PTH are potential alternatives.

  1. Bauman W, Wecht J, Kirshblum S, Spungen A, Morrison N, Cirnigliaro C, Schwartz E. (2005) Effect of pamidronate administration on bone in patients with acute spinal cord injury. Journal of Rehabilitaion Research and Development. 42(3) 305-314
  2. Bloomfield S. (1997) Changes in musculoskeletal structure and function with prolonged bed rest. Med Sci Sports Exer 29 (2) 197-206
  3. Booth KA, Hays CI (2014). Using denosumab to treat immobilisation hypercalcaemia in a post-acute care patient. JCEM 99 (10) 3531-3535.
  4. Ichinose Y, Tanaka H, Inoue M, Mochizuki S, Tsuda E, Seino Y. (2003) Osteoclastogenesis inhibitory factor / osteoprotegrin reduced bone loss induced by mechanical unloading. Calcified Tissue International. 75: 338-343.
  5. LeBlanc, A. D., V. S. Schneider, H. J. Evans, D. A. Engelbretson, and J. M. Krebs. (1990) Bone mineral loss and recovery after 17 weeks of bed rest. J. Bone Miner. Res. 5:843-850.
  6. Shen V, Liang XG, Birchman R, Wu DD, Healy r, Lindsya R, Dempster DW. (1997) Short-term immobilisation-induced cancellous bone loss is limited to regions undergoing high turnover and/or modelling in mature rats. Bone 21(1) 71-78
  7. Wheater G, Elshahaly M, Tuck SP, Datta HK, van Laar JM. (2013) The clinical utility of bone marker measurements in osteoporosis. Journal of Translational Medicine. 11: 201